SynthesisFrontiers in pharmacology2024

What are the benefits of therapeutic drug monitoring in the optimization of adalimumab therapy? a systematic review and meta-analysis up to 2022.

Yun Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.